발생일자 2014.10.03 

사건번호 1:14-cv-01271 

법원국가 UNITED STATES OF AMERICA 

관할법원명 D.C.Delaware(지방법원) 

침해권리 의약품 

원고명 Forest Laboratories, LLC/ Forest Laboratories Holdings Ltd./ Adamas Pharmaceuticals, Inc. ( 미국 / 외국기업 )  

피고명 Amerigen Pharmaceuticals, Inc./ Amerigen Pharmaceuticals Ltd. ( 미국 / 외국기업 )  

소송유형 침해금지 

[Forest Laboratories, LLC et al v. Amerigen Pharmaceuticals, Inc. et al] 사건번호 1:14-cv-01271에 따르면 원고 Forest Laboratories, LLC/ Forest Laboratories Holdings Ltd./ Adamas Pharmaceuticals, Inc.는 피고 Amerigen Pharmaceuticals, Inc./ Amerigen Pharmaceuticals Ltd.을 상대로 특허 US8039009|US8168209|US8173708|US8283379|US8329752|US8362085|US8598233을 침해하였다는 이유로 미국 델라웨어 지방법원에 소를 제기하였다. 

분쟁결과 분쟁중 

산업분류 화학∙바이오 > 의약품 

계쟁제품 Generic extended release capsule products containing 7, 14, and 28 milligrams of memantine hydrochloride as the active ingredient 

지재권번호/명칭 US8039009   Modified release formulations of memantine oral dosage forms 

 US8168209   Method and composition for administering an NMDA receptor antagonist to a subject 

 US8173708   Method and composition for administering an NMDA receptor antagonist to a subject 

 US8283379   Methods and compositions for the treatment of CNS-related conditions 

 US8329752   Composition for administering an NMDA receptor antagonist to a subject 

 US8362085   Method for administering an NMDA receptor antagonist to a subject 

 US8598233   Method for administering an NMDA receptor antagonist to a subject